Dual-peptide research blend containing CJC-1295 without DAC (Mod GRF 1-29) and Ipamorelin,
CJC-1295 without DAC is a modified GHRH analogue, also known as Mod GRF 1-29. Ipamorelin is a selective agonist of the growth hormone secretagogue receptor GHS-R1a. The blend is studied in laboratory and preclinical research models relating to growth-hormone signalling and interactions between the GHRH and GHS pathways. For laboratory research only. Not for human or veterinary use.
The following information is provided for research-catalogue and product specification purposes only. Batch-specific identity, purity, salt form and analytical values should be confirmed against the relevant Certificate of Analysis.
| What it is | CJC-1295 without DAC is a modified GHRH analogue, also known as Mod GRF 1-29. Ipamorelin is a selective agonist of the growth hormone secretagogue receptor GHS-R1a. The blend is studied in laboratory and preclinical research models relating to growth-hormone signalling and interactions between the GHRH and GHS pathways. For laboratory research only. Not for human or veterinary use. |
|---|---|
| Sequence | CJC-1295 no DAC: H-Tyr-D-Ala-Asp-Ala-Ile-Phe-Thr-Gln-Ser-Tyr-Arg-Lys-Val-Leu-Ala-Gln-Leu-Ser-Ala-Arg-Lys-Leu-Leu-Gln-Asp-Ile-Leu-Ser-Arg-NH2; Ipamorelin: Aib-His-D-2-Nal-D-Phe-Lys-NH2 |
| Molecular weight | CJC-1295 no DAC: 3367.9 g/mol; Ipamorelin: 711.9 g/mol |
| Product family | GHRH + GHS Research Blends |
| Research classification | GHRH analogue + GHS-R1a agonist / Growth-hormone signalling research blend |
| Form | Lyophilised peptide blend |
| Appearance | White to off-white lyophilised powder |
| Fill quantity | 10mg |
| Container type | Sealed glass vial |
| Storage | Store at 2–8°C for short-term storage or at −20°C for long-term storage. Protect from light and moisture. Avoid repeated freeze-thaw cycles and refer to the batch-specific Certificate of Analysis. |
| Synonyms | Mod GRF 1-29 + Ipamorelin; CJC-1295 no DAC + IPA; CJC/IPA blend; GHRH/GHS blend |
| CAS number | CJC-1295 no DAC: 863288-34-0; Ipamorelin: 170851-70-4 |
| Molecular form / formula | CJC-1295 no DAC: C152H252N44O42; Ipamorelin: C38H49N9O5 |
| Molecule form | Amidated peptide blend; salt form according to batch COA |
| Purity | ≥98% per component (HPLC; batch-specific COA) |
| Analysis method | HPLC and mass spectrometry (MS) |
Each compound is accompanied by third-party analytical documentation where available. Certificates confirm purity, identity and chromatographic analysis against the supplied batch.
Orders are typically processed within 1–2 business days of confirmed payment. Estimated delivery to the United States and Canada is 7–14 business days after dispatch; other international destinations are typically 10–21 business days. All shipping is tracked and discreetly packaged.
Store at 2–8°C for short-term storage or at −20°C for long-term storage. Protect from light and moisture. Avoid repeated freeze-thaw cycles and refer to the batch-specific Certificate of Analysis.
| Form | Lyophilised peptide blend |
|---|---|
| Appearance | White to off-white lyophilised powder |
| Container type | Sealed glass vial |
| Storage & Handling | Store at 2–8°C for short-term storage or at −20°C for long-term storage. Protect from light and moisture. Avoid repeated freeze-thaw cycles and refer to the batch-specific Certificate of Analysis. |
All products are supplied by Greek Peptides for research use only. They are not licensed as pharmaceuticals and are not promoted as, or intended to diagnose, treat, cure, prevent or mitigate any disease or medical condition in humans or animals. They are not intended for human or animal consumption and are not intended for cosmetic, nutritional or recreational use.
By purchasing, the purchaser confirms that they are a qualified individual acting for legitimate research purposes only and accepts our Terms and Conditions and Research Use Policy.
